Medtronic Reports Q3 Revenue Growth of 2.5%, Below Market Expectations

Gelonghui February 18 | Medical technology company Medtronic announced its third-quarter performance for the fiscal year 2025 ended January 24, with revenue increasing by 2.5% year-over-year to $8.29 billion, below analysts' expectations of $8.33 billion; adjusted earnings per share were $1.39, compared to analysts' expectations of $1.36. Growth in the cardiovascular portfolio and neuroscience division offset the decline in the medical surgical business.

Medtronic Reaffirms Full-Year Revenue to Grow 4.75% to 5% Year-over-Year, Earnings per Share Between $5.44 and $5.50, Analysts Expect $5.45